Granulocyte Colony-Stimulating Factor: all 180 studies that test it
Page 2 of 2. Open to participants first (24), then studies with results posted, then the rest; newest registration first within each.
- Cladribine in Combination With GAP in Patients With Refractory/Relapsed Acute Lymphoblastic LeukemiaStatus unknownNCT03318419Phase 2
- Cladribine in Combination With CAG in Patients With Refractory/Relapsed Acute Myeloid LeukemiaStatus unknownNCT03181815Phase 2
- G-CSF Plus NAC In Severe Alcoholic HepatitisStatus unknownNCT02971306Phase 4
- G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant TumorStatus unknownNCT02933333Phase 4
- G-CSF and Autologous Cord Blood Infusion in Cerebral PalsyStatus unknownNCT02866331Phase 2
- The Efficacy of G-CSF Against Adhesion Reformation After Hysteroscopic AdhesiolysisStatus unknownNCT02855632Not applicable
- A Clinical Trial of Omacetaxine, Azacitidine, and Growth-Colony Stimulating Factor (G-CSF) for Myelodysplastic Syndromes (MDS)WithdrawnNCT02835794Phase 1/2
- Efficacy Safety of Granulocyte Colony-stimulating Factor Treatment Children and Adolescents With Muscular DystrophyStatus unknownNCT02814110Phase 1
- G-CSF+Decitabine+BUCY vs BUCY Conditioning Regimen for RAEB-1, REAB-2 and AML Secondary to MDS Undergoing Allo-HSCTCompletedNCT02744742Phase 2/3
- Evaluation of Pharmacokinetic/Pharmacodynamic Properties and Safety of Leucostim® Compared to Neupogen® in Healthy Adult VolunteersCompletedNCT02725086Phase 1
- Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and PlerixaforCompletedNCT02678533Phase 1/2
- Granulocyte Colony Stimulating Factor (G-CSF) to Treat Acute-on-chronic Liver FailureCompletedNCT02669680Not applicable
- To Assess the Efficacy of Granulocyte Colony Stimulating Factor Versus Standard Medical Therapy in Patients of Decompensated CirrhosisCompletedNCT02642003Phase 3
- Granulocyte Colony Stimulating Factor And Growth Hormone In Cirrhosis Of Liver: An Open Label StudyCompletedNCT02451033Phase 2/3
- Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell LymphomaActive, not recruitingNCT02436707Phase 2
- Granulocyte Colony Stimulating Factor (G-CSF) After Salvage Chemotherapy in Refractory AMLStatus unknownNCT02427919Phase 2/3
- RCT Study on Granulocyte Colony-stimulating Factor(G-CSF) Treatment of Hepatic FailureStatus unknownNCT02331745Phase 4
- Phase I Study of Bortezomib With G-CSF for Stem Cell Mobilization in Patients With Multiple MyelomaCompletedNCT02220608Phase 1
- REaCT Integrated Consent Model to Compare Two Standard of Care RegimensCompletedNCT02173262Phase 4
- Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor SourceCompletedNCT02167958Phase 1
- Evaluation of G-CSF (Colony Stimulating Factor) in Patients With Chronic Chagas CardiomyopathyCompletedNCT02154269Phase 2
- A Phase 2 Trial of Filanesib in Relapsed/Refractory Multiple Myeloma (AfFIRM)CompletedNCT02092922Phase 2
- Combination of G-CSF, Bortezomib, Cyclophosphamide and Dexamethasone in Patients With Multiple MyelomaStatus unknownNCT02027220Phase 2
- A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple MyelomaCompletedNCT01989325Phase 2
- A Trial to Study the Influence of Growth Factors on Bone Marrow and Hepatic Regeneration in Patients With Decompensated Cirrhosis.CompletedNCT01902511Not applicable
- The Effect of GCSF in the Treatment of ALS PatientsCompletedNCT01825551Phase 2/3
- Dose Adjusted EPOCH-R, to Treat Mature B Cell MalignanciesCompletedNCT01760226Early Phase 1
- Risk Adapted Treatment for Primary Acute Myeloid Leukemia (AML)CompletedNCT01723657Phase 2
- High Dose Chemotherapy and Autologous Transplant for NeuroblastomaCompletedNCT01526603Not applicable
- ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid LeukemiaWithdrawnNCT01478074Phase 1
- Treatment of Relapsed or Refractory Acute Myeloblastic LeukemiaCompletedNCT01435343Phase 1/2
- Healthy Donor Study II - Comparing Plerixafor With G-CSF and PlerixaforCompletedNCT01403896Phase 2
- G-CSF and Erythropoetin in Survival of Patients With Decompensated Liver DiseaseCompletedNCT01384565Phase 3
- The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBCStatus unknownNCT01378533Phase 3
- Granulocyte Colony Stimulating Factor (G-CSF) in Acute Liver Failure and Alcoholic HepatitisStatus unknownNCT01341951Not applicable
- Disrupting the Bone Marrow Microenvironment With G-CSF in Acute Lymphoblastic LeukemiaCompletedNCT01331590Early Phase 1
- Bone Marrow Derived Adult Stem Cells for Dilated CardiomyopathyCompletedNCT01302171Phase 2
- Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for LeukemiaCompletedNCT01297543Phase 1/2
- PAV-trial: Plerixafor and Chemotherapy With Vinorelbine for Stem Cell Mobilization in Patients With MyelomaCompletedNCT01220375Phase 2
- Plerixafor Harvesting And No Chemotherapy for Transplantation of Autologous STem Cells In Cancer (PHANTASTIC)CompletedNCT01186224Not applicable
- A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or LymphomaCompletedNCT01171092Early Phase 1
- Randomized Study In Severe Aplastic Anemia Patients Receiving Atg, Cyclosporin A, With Or Without G-CSF (SAA-G-CSF)TerminatedNCT01163942Phase 3
- Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) in Combination With Azacitidine for the Treatment of Myelodysplastic Syndrome (MDS)CompletedNCT01065129Phase 1
- Granulocyte Colony Stimulating Factor(G-CSF) Therapy for Patients With ACLFStatus unknownNCT01036932Not applicable
- Granulocyte Colony-stimulating Factor (G-CSF) Plus or Minus AMD3100 for Engraftment Post Allogeneic TransplantCompletedNCT01026987Phase 1
- Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 MutationsCompletedNCT00943943Phase 1
- Induction With or Without Granulocyte Colony-Stimulating Factor in AML Transplantation in AMLCompletedNCT00820976Phase 3
- Stem Cell Mobilization by G-CSF to Treat Severe Peripheral Artery DiseaseCompletedNCT00797056Early Phase 1
- Use of G-CSF for the Treatment of Unexplained Recurrent MiscarriageCompletedNCT00772122Phase 4
- The Effect of Granulocyte Colony Stimulating Factor (G-CSF) on Myocardial Function After Acute Anterior Myocardial Infarction, a Prospective Double Blind Randomized Placebo Controlled StudyCompletedNCT00756756Not applicable
- Total Marrow Irradiation for Refractory Acute LeukemiaCompletedNCT00686556Phase 1
- Nonmyeloablative Allo SCT for the Treatment of Hematologic DisordersCompletedNCT00636909Phase 2
- Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCTCompletedNCT00516152Phase 2
- Cord Blood Expansion on Mesenchymal Stem CellsCompletedNCT00498316Phase 1
- Autologous Stem Cell Transplants for Chronic Myelogenous LeukemiaWithdrawnNCT00446173Phase 2
- G-CSF Treatment for Amyotrophic Lateral Sclerosis: A RCT Study Assessing Clinical ResponseCompletedNCT00397423Phase 2
- Stem Cell Mobilization by G-CSF Post Myocardial Infarction to Promote Myocyte RepairStatus unknownNCT00394498Phase 2/3
- Cell Therapy in Chagas CardiomyopathyTerminatedNCT00349271Phase 3
- Myocardial Regeneration and Angiogenesis in Myocardial Infarction With G-CSF and Intra-Coronary Stem Cell InfusionTerminatedNCT00307879Phase 2
- Influence of G-CSF and EPO on Associative Learning and Motor SkillsCompletedNCT00298597Phase 2
- Myocardial Regeneration and Angiogenesis in Myocardial Infarction With G-CSF and Intra-Coronary Stem Cell Infusion-3-DESCompletedNCT00291629Phase 2
- Biology and Treatment Strategy of AML in Its Subgroups: Multicenter Randomized Trial by the German Acute Myeloid Leukemia Cooperative Group (AMLCG)CompletedNCT00266136Phase 3
- Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of EsophagusTerminatedNCT00208936Phase 2
- Efficacy of G-CSF-Priming in Elderly AML PatientsStatus unknownNCT00199147Phase 4
- Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in AdultsCompletedNCT00199082Phase 4
- German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)CompletedNCT00198991Phase 4
- German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00198978Phase 4
- Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks; Wkly Taxol x 12CompletedNCT00194753Phase 2
- A Phase II Study of Topotecan in Children With Recurrent Wilms TumorCompletedNCT00187031Phase 2
- ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159CompletedNCT00168168Not applicable
- Treatment With AX200 for Acute Ischemic StrokeCompletedNCT00132470Phase 2
- Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell TumorsStatus unknownNCT00127049Phase 2
- Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic CancerCompletedNCT00053196Phase 2
- G-CSF to Treat Crohn's DiseaseCompletedNCT00025805Phase 1
- Stem Cell Mobilization Potential in Patients With Aplastic Anemia in RemissionCompletedNCT00011830Phase 1
- Mobilization of Stem Cells With G-CSF for Collection From Patients With Diamond-Blackfan AnemiaCompletedNCT00011505Phase 2
- Mobilization and Handling of Stem Cells for Transplant From Healthy Volunteers With Sickle Cell TraitCompletedNCT00005782Phase 3
- Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid TumorsCompletedNCT00003597Phase 1
- A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian CancerCompletedNCT00001426Phase 2
- A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer PatientsCompletedNCT00001384Phase 2